-
Je něco špatně v tomto záznamu ?
Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes
J. Vrba, M. Havlikova, D. Gerhardova, J. Ulrichova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- berberin chemie farmakologie MeSH
- berberinové alkaloidy chemie farmakologie MeSH
- buňky Hep G2 MeSH
- cytochrom P-450 CYP1A1 genetika metabolismus MeSH
- cytochrom P-450 CYP1A2 genetika metabolismus MeSH
- hepatocyty účinky léků MeSH
- lidé MeSH
- molekulární struktura MeSH
- receptory aromatických uhlovodíků genetika metabolismus MeSH
- regulace genové exprese účinky léků MeSH
- transkripční faktory bHLH genetika metabolismus MeSH
- viabilita buněk MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The protoberberine alkaloid palmatine is present in preparations from medicinal plants such as Coptis chinensis and Corydalis yanhusuo. This study examined whether palmatine affects the expression of cytochromes P450 (CYPs) 1A1 and 1A2 in primary cultures of human hepatocytes and human hepatoma HepG2 cells grown as monolayer or spheroids. Gene reporter assays showed that palmatine significantly activated the aryl hydrocarbon receptor (AhR) and increased the activity of CYP1A1 gene promoter in transiently transfected HepG2 cells. In HepG2 monolayer culture, palmatine also significantly increased mRNA and activity levels of CYP1A1, albeit with considerably less potency than 2,3,7,8-tetrachlorodibenzo-p-dioxin, a prototypical CYP1A inducer. On the other hand, CYP1A activity was not significantly elevated by palmatine in HepG2 spheroids. Moreover, palmatine induced mild or negligible changes in CYP1A1 and CYP1A2 mRNA expression without affecting CYP1A activity levels in primary human hepatocytes. It is concluded that palmatine activates the AhR-CYP1A pathway in HepG2 monolayer, while the potential for CYP1A induction is irrelevant in cell systems which are closer to the in vivo situation, i.e. in HepG2 spheroids and primary cultures of human hepatocytes. Possible induction of CYP1A enzymes by palmatine in vivo remains to be investigated.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023555
- 003
- CZ-PrNML
- 005
- 20150723103824.0
- 007
- ta
- 008
- 150709s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tiv.2014.02.008 $2 doi
- 035 __
- $a (PubMed)24583342
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vrba, Jiri $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic. Electronic address: vrbambv@seznam.cz.
- 245 10
- $a Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes / $c J. Vrba, M. Havlikova, D. Gerhardova, J. Ulrichova,
- 520 9_
- $a The protoberberine alkaloid palmatine is present in preparations from medicinal plants such as Coptis chinensis and Corydalis yanhusuo. This study examined whether palmatine affects the expression of cytochromes P450 (CYPs) 1A1 and 1A2 in primary cultures of human hepatocytes and human hepatoma HepG2 cells grown as monolayer or spheroids. Gene reporter assays showed that palmatine significantly activated the aryl hydrocarbon receptor (AhR) and increased the activity of CYP1A1 gene promoter in transiently transfected HepG2 cells. In HepG2 monolayer culture, palmatine also significantly increased mRNA and activity levels of CYP1A1, albeit with considerably less potency than 2,3,7,8-tetrachlorodibenzo-p-dioxin, a prototypical CYP1A inducer. On the other hand, CYP1A activity was not significantly elevated by palmatine in HepG2 spheroids. Moreover, palmatine induced mild or negligible changes in CYP1A1 and CYP1A2 mRNA expression without affecting CYP1A activity levels in primary human hepatocytes. It is concluded that palmatine activates the AhR-CYP1A pathway in HepG2 monolayer, while the potential for CYP1A induction is irrelevant in cell systems which are closer to the in vivo situation, i.e. in HepG2 spheroids and primary cultures of human hepatocytes. Possible induction of CYP1A enzymes by palmatine in vivo remains to be investigated.
- 650 _2
- $a transkripční faktory bHLH $x genetika $x metabolismus $7 D051792
- 650 _2
- $a berberin $x chemie $x farmakologie $7 D001599
- 650 _2
- $a berberinové alkaloidy $x chemie $x farmakologie $7 D001600
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a cytochrom P-450 CYP1A1 $x genetika $x metabolismus $7 D019363
- 650 _2
- $a cytochrom P-450 CYP1A2 $x genetika $x metabolismus $7 D019388
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatocyty $x účinky léků $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a receptory aromatických uhlovodíků $x genetika $x metabolismus $7 D018336
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Havlikova, Marika $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic.
- 700 1_
- $a Gerhardova, Denisa $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic.
- 700 1_
- $a Ulrichova, Jitka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic.
- 773 0_
- $w MED00004536 $t Toxicology in vitro an international journal published in association with BIBRA $x 1879-3177 $g Roč. 28, č. 4 (2014), s. 693-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24583342 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150723103902 $b ABA008
- 999 __
- $a ok $b bmc $g 1083892 $s 906548
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 28 $c 4 $d 693-9 $i 1879-3177 $m Toxicology in vitro $n Toxicol In Vitro $x MED00004536
- LZP __
- $a Pubmed-20150709